Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
75 Cards in this Set
- Front
- Back
Used to treat status asthmaticus (severe asthma that cannot be controlled with typical medications)
|
Xanthines
|
|
Administer cautiously to the elderly b/c of potential for increased sensitivity
|
Xanthines
|
|
Use cautiously in clients with cardiovascular disorders
|
Xanthines
|
|
potential for cardiovascular collapse
|
Xanthines
|
|
food interactions: caffeine
|
Xanthines
|
|
Assess for toxicity; note symptoms of restlessness, insomnia, irritability, tremors, n/v
|
Xanthines
|
|
Restlessness is a symptom of toxic reaction; however, it could signal hypoxia, and the nurse should assess client for this
|
Xanthines
|
|
Do not omit or double-up on doses; take exactly as prescribed
|
Xanthines
|
|
Notify prescriber if palpitations, n/v, weakness, dizziness, chest pain or convulsions occur
|
Xanthines
|
|
Beta-andrenergics & Xanthines
What type of meds are these? |
Bronchidilators
|
|
May see adverse effect if used too frequently (elevated HR, nausea anxiety, palpitations, and tremors)
|
beta-andrenergics
|
|
Use with caution in young children and monitor for tremors, restlessness, hallucinations, dizziness, palpitations, tachycardia, gastrointestinal difficulties
|
beta-andrenergics
|
|
Contraindicated in clients with tachyarrhythmias and severe CAD
(specifically) |
beta-andrenergics
(Albuterol) |
|
Children under 12 should not use certain ones
|
beta-andrenergic inhalants
|
|
Concurrent use of MAO inhibitors may lead to hypertensive crisis
|
beta-andrenergics
|
|
Paradoxic bronchospasm and urinary retention
|
beta-andrenergics
|
|
Monitor elderly clients carefully
|
beta-andrenergics
|
|
Monitor VS, esp HR and BP when administering
|
beta-andrenergics
|
|
Ensure proper use of MDI
|
beta-andrenergics
|
|
Note amount, color, and character of sputum
|
beta-andrenergics
|
|
Monitor blood glucose level closely in diabetic clients
|
beta-andrenergics
|
|
Report chest pain, palpitations, seizures, headaches, hallucinations, or blurred vision to prescriber
|
beta-andrenergics
|
|
Do not take more than the prescribed dose b/c of risk of hypertension, tachycardia, dysrhythmias, and angina
|
beta-andrenergics
|
|
Avoid eye contact with inhaler spray
|
beta-andrenergics
|
|
Take medication exactly as ordered; do not double dosage or increase frequency of doses
|
beta-andrenergics
|
|
Treatment of choice for acute asthma attack
|
beta-andrenergics
|
|
Stimulation of alpha-adrenergic receptors results in vasoconstriction and increased systemic BP
|
antihypotensives (sympathomimetics)
|
|
Must be diluted before administration
|
antihypotensives (sympathomimetics)
|
|
Client should be attended constantly during drug administration
|
antihypotensives (sympathomimetics)
|
|
Reevaluate if 3-5 treatments in 6-12 hours provide minimal to no relief
|
antihypotensives (sympathomimetics)
|
|
Carefully monitor VS, ECG, and I&O
|
antihypotensives (sympathomimetics)
|
|
Monitor for rebound hypertension
|
antihypotensives (sympathomimetics)
|
|
Constant infusion pump prevents sudden infusion of excessiv amounts of drugs
|
antihypotensives (sympathomimetics)
|
|
Correct blood volume depletion first
|
antihypotensives (sympathomimetics)
|
|
Antidote for extravasation: phyentolamine mesylate (Regitine) in NS
|
antihypotensives (sympathomimetics)
|
|
Protect solution from sunlight
|
antihypotensives (sympathomimetics)
|
|
incompatible with sodium bicarbonate
|
antihypotensives (sympathomimetics)
|
|
side effect: sensitivity to light, blurred vision
|
urinary tract anti-infectives
|
|
Adverse effects: leukopenia, thrombocytopenia, angioedema
|
urinary tract anti-infectives
|
|
Cranberry juice or vitamin C may be added
|
urinary tract anti-infectives
|
|
rinse mouth to avoid staining teeth (specifically?)
|
urinary tract anti-infectives
(nitrofurantoin) |
|
Drink at least 8 glasses of water daily
|
urinary tract anti-infectives
|
|
avoid alkalizing fluids such as milk, fruit juice, or sodium bicarbonate; do not take antacids
|
urinary tract anti-infectives
|
|
use sunscreen
|
urinary tract anti-infectives
|
|
may discolor urine, not harmful, will turn back after treatment
|
urinary tract anti-infectives
|
|
contraindications: hypersensitivity to anticholinergics, paralytic ileus, unstable CV status
|
bladder antispasmodics
|
|
side effects: headache, insomnia, drowsiness, dizziness, confusion, excitement, palpitations, blurred vision, dry mouth, GI distress, urinary hesitancy, urine hesitancy, urine retention, urticaria
|
bladder antispasmodics
|
|
monitor for CNS manifestations
|
bladder antispasmodics
|
|
monitor effect of medication
|
bladder antispasmodics
|
|
may be used with antibiotics and should be discontinued after 2 days of antibiotic use
|
urinary analgesics
|
|
assess for presence of UTI
|
urinary analgesics
|
|
drug colors urine red/orange and may stain clothing
|
urinary analgesics
|
|
do not double dose if dose missed
|
urinary analgesics
|
|
drug may not be effective for more than 24-48 hour period
|
urinary analgesics
|
|
notify prescriber if yellowing of eyes
|
urinary analgesics
|
|
side effects: impotence, decreased volume of ejaculate, decreased libido, asthenia (no shit guys hesitate to take this stuff)
|
BPH meds
|
|
monitor urine volume
|
BPH meds
|
|
orthostatic hypotension
|
BPH meds
|
|
avoid driving, drowsiness and somnolence
|
BPH meds
|
|
Pregnant, should not handle crushed tables due to risk of adverse effect to male fetus
|
BPH meds (finasteride)
|
|
Male client, pregnant partner, avoid semen
|
BPH meds
|
|
IV infusion device
|
Renal failure meds
|
|
side effects: headache, tachycardia, angina, palpitations, hypotension, bradycardia, vasoconstriction, widening of QRS complex
|
Renal failure meds
|
|
Hct reach normal levels (30-33%) in 2-3 months
|
Hematopoietic Growth Factor
|
|
Do not shake solution
|
Hematopoietic Growth Factor
|
|
Evaluate transferrin and serum ferritin prior to initiation of therapy
|
Hematopoietic Growth Factor
|
|
side effects: hypertension, headache, seizure, iron deficiency, sweating
|
Hematopoietic Growth Factor
|
|
blood pressure may rise during early therapy as the Hct increases; notify if greater than 4 points in 2 weeks
|
Hematopoietic Growth Factor
|
|
Client may require additional heparin during dialysis to prevent clotting of vascular access
|
Hematopoietic Growth Factor
|
|
self monitor vs, esp. BP
|
Hematopoietic Growth Factor
|
|
avoid driving, possible seizure activity, esp first 90 days of therapy
|
Hematopoietic Growth Factor
|
|
client should be instructed to monitor for signs of infection
|
organ rejection meds (cyclosporine, Neoral)
|
|
grapefruit can raise levels, increasing risk of toxicity
|
organ rejection meds (cyclosporine, Neoral)
|
|
mix concentrated medication solution with milk, chocolate milk, orange juice
|
organ rejection meds (cyclosporine, Neoral)
|
|
can cause neutropenia
|
organ rejection meds (azathiprine, Imuran)
|